{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15788", "batch_size": 200, "batch_pos": 170, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, or intensifier + harm noun.", "method": "llm_batch", "batch_id": "batch_2_14828", "batch_size": 200, "batch_pos": 137, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb from the specified list paired with explicit scale or impact information.", "method": "llm_batch", "batch_id": "batch_3_19408", "batch_size": 200, "batch_pos": 79, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment is a statement, not a question.", "method": "llm_batch", "batch_id": "batch_4_20584", "batch_size": 200, "batch_pos": 73, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Lacks explicit calming language or keywords.", "method": "llm_batch", "batch_id": "batch_5_19136", "batch_size": 200, "batch_pos": 68, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser or scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_18748", "batch_size": 200, "batch_pos": 19, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_19140", "batch_size": 200, "batch_pos": 8, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "Describes a potential future risk, not capability or preparedness.", "method": "llm_batch", "batch_id": "batch_8_14172", "batch_size": 200, "batch_pos": 8, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "Discusses uncertainty about a future metric, not factual reporting of current metrics.", "method": "llm_batch", "batch_id": "batch_9_16392", "batch_size": 200, "batch_pos": 155, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment does not speculate about potential future relief or improvement.", "method": "llm_batch", "batch_id": "batch_10_4752", "batch_size": 200, "batch_pos": 49, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Quote is present but contains neutral content, not framing risk or safety.", "method": "llm_batch", "batch_id": "batch_11_11824", "batch_size": 200, "batch_pos": 45, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Statement about uncertainty regarding manufacturing capacity, no explicit framing cues.", "method": "llm_batch", "batch_id": "batch_12_4876", "batch_size": 200, "batch_pos": 45, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
